Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Laurence H Keller"'
Autor:
Smeeta Sinha, Sagar U. Nigwekar, Vincent Brandenburg, Lisa J. Gould, Thomas E. Serena, Sharon M. Moe, George R. Aronoff, Dinesh K. Chatoth, Jeffrey L. Hymes, Kevin J. Carroll, Gabriela Alperovich, Laurence H. Keller, Joan Perelló, Alex Gold, Glenn M. Chertow
Publikováno v:
EClinicalMedicine, Vol 75, Iss , Pp 102784- (2024)
Summary: Background: In the CALCIPHYX trial, we investigated hexasodium fytate, an inhibitor of vascular calcification, for the treatment of calcific uraemic arteriolopathy (calciphylaxis), a rare condition characterised by painful, non-healing skin
Externí odkaz:
https://doaj.org/article/ed79d86af030474a941e83bc9d1bd82e
Autor:
Naomi Hamburg, Alik Farber, Marc P Bonaca, Manesh R Patel, William A Marston, Stephan Miller, Claire Padgett, Laurence H Keller, Joan Perelló, Alex Gold, Glenn M Chertow
Publikováno v:
Circulation. 144
Background: Patients with peripheral artery disease and end-stage kidney disease (PAD-ESKD) have poor outcomes that may be related to the presence of medial arterial calcification. These patients have been excluded from prior studies of medical inter
Autor:
Philip Evans, Stephen A. Wring, David Carpenter, Michelle Palacios, Katelyn Crizer, Julie Rurka, Laurence H Keller, Michele Snyder
Publikováno v:
Pulmonary hypertension.
Background: Pulmonary arterial endothelial cell tryptophan hydroxylase (TPH) expression is upregulated in pulmonary arterial hypertension (PAH) leading to elevated serotonin that drives proliferation of pulmonary artery smooth muscle cells (PASMCs),
Autor:
David Carpenter, Stephen A. Wring, Thomas Pack, Laurence H Keller, Julie Rurka, Michele Snyder, Katelyn Crizer, Michelle Palacios
Publikováno v:
Chest. 156:A1175-A1176
Autor:
Laurence H Keller
Publikováno v:
Congestive Heart Failure. 15:202-206
Adult stem cell populations selected for use in cardiovascular clinical trials typically are mononuclear cell fractions of bone marrow and peripheral blood or cells of specific cell lineages selected by surface markers such as CD34 or CD133. This art
Autor:
Michael H. Davidson, James M. McKenney, Daiva R. Bajorunas, Richard H. Karas, Laurence H. Keller, Christie M. Ballantyne
Publikováno v:
The American Journal of Cardiology. 101:1428-1436
The efficacy and safety of 2 regimens of a combination of a proprietary niacin extended release plus simvastatin (NER/S; 1,000/20 and 2,000/20 mg/day) were compared with simvastatin monotherapy (20 mg/day) for 24 weeks in 319 high-risk patients with
Autor:
Michael H. Davidson, James M. McKenney, Laurence H. Keller, Richard H. Karas, Christie M. Ballantyne, Daiva R. Bajorunas
Publikováno v:
Journal of Clinical Lipidology. 2:79-90
Background The number of patients with multiple lipid abnormalities is increasing. Lipid treatment guidelines are established for low-density lipoprotein cholesterol (LDL-C) and non–high-density lipoprotein cholesterol (non–HDL-C). The importance
Autor:
Michael H. Davidson, Moti L. Kashyap, Richard H. Karas, Laurence H. Keller, Daiva R. Bajorunas, Robert H. Knopp
Publikováno v:
American Journal of Cardiovascular Drugs. 8:69-81
High-dose HMG-CoA reductase inhibitors (statins) fail to prevent approximately two-thirds of cardiovascular events. This fact has focused increased attention on treating abnormalities of non-high-density lipoprotein-cholesterol (non-HDL-C), HDL-C, an
Autor:
Dilip R. Karnad, Erica Caveney, J. Rick Turner, Laurence H Keller, Snehal Kothari, Barbara S Gillespie, Alan Metz
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy. :pvw047
Autor:
Marlos R. Fernandes, J. Patrick Herlihy, W. H. Moore, John Canales, Dipsu Patel, Amir Gahremanpour, Guilherme V. Silva, James T. Willerson, Yi Zheng, Laurence H Keller, Xin Quan, Emerson C. Perin, Stephanie A Coulter
Publikováno v:
American heart journal. 163(3)
Background The optimal type of stem cell for use in patients with ischemic heart disease has not been determined. A primitive population of bone marrow–derived hematopoietic cells has been isolated by the presence of the enzyme aldehyde dehydrogena